1. The era of antimicrobial resistance—implications for the clinical laboratory 
D.E. Low 
Clinical Microbiology and Infection 
Volume 8, Pages 9-20 (January 2002)
DOI: /j s.3.2.x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Macrolide resistance among Streptococcus pneumoniae isolates from various countries (resistance defined as erythromycin MIC ≥1 mg/L). Alexander Project 2000.
data on file—GlaxoSmithKline (manuscript in preparation)
Clinical Microbiology and Infection 2002 8, 9-20DOI: ( /j s.3.2.x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Distribution of erythromycin resistance phenotypes among 249 strains of erythromycin-resistant Streptococcus pneumoniae.
collected by the Canadian Bacterial Surveillance Network from across Canada in 2000
Clinical Microbiology and Infection 2002 8, 9-20DOI: ( /j s.3.2.x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Penicillin resistance among isolates of Streptococcus pneumoniae isolates from various countries.
Alexander Project 2000, data on file—GlaxoSmithKline (manuscript in preparation).
Clinical Microbiology and Infection 2002 8, 9-20DOI: ( /j s.3.2.x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

5. Fig. 4
Association between fluoroquinolone prescriptions per capita and percentage of pneumococci with reduced susceptibility to fluoroquinolones in Canada in two age groups. Solid bars represent 15–64-year age group; open bars represent > 65-year age group.
Reproduced from Chen et al. [42] with permission.
Clinical Microbiology and Infection 2002 8, 9-20DOI: ( /j s.3.2.x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions